PDL1 expression in NSCLC (non-small cell lung cancer) patients and its influence on treatment decision - experience from Portsmouth Oncology Centre

Gyi M. M.; Gulliford T. J.; Muthuramalingam S. R.

首页> 外文期刊>Lung cancer: Journal of the International Association for the Study of Lung Cancer >PDL1 expression in NSCLC (non-small cell lung cancer) patients and its influence on treatment decision - experience from Portsmouth Oncology Centre

【24h】

PDL1 expression in NSCLC (non-small cell lung cancer) patients and its influence on treatment decision - experience from Portsmouth Oncology Centre

机译：NSCLC（非小细胞肺癌）患者的PDL1表达及其对治疗决策的影响 - 来自朴茨茅斯肿瘤学中心的经验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Lung cancer: Journal of the International Association for the Study of Lung Cancer》 |2018年第1期|共2页
作者
Gyi M. M.; Gulliford T. J.; Muthuramalingam S. R.;
展开▼
作者单位

Queen Alexandra Hosp Portsmouth Oncol Ctr Portsmouth Hants England;

Queen Alexandra Hosp Portsmouth Oncol Ctr Portsmouth Hants England;

Queen Alexandra Hosp Portsmouth Oncol Ctr Portsmouth Hants England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. PDL1 expression in NSCLC (non-small cell lung cancer) patients and its influence on treatment decision - experience from Portsmouth Oncology Centre [J] . Gyi M. M., Gulliford T. J., Muthuramalingam S. R. Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2018,第期

机译：NSCLC（非小细胞肺癌）患者的PDL1表达及其对治疗决策的影响 - 来自朴茨茅斯肿瘤学中心的经验
2. PDL1 expression in NSCLC (non-small cell lung cancer) patients and its influence on treatment decision - experience from Portsmouth Oncology Centre [J] . Gyi M. M., Gulliford T. J., Muthuramalingam S. R. Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2018,第Suppla1期

机译：NSCLC（非小细胞肺癌）患者的PDL1表达及其对治疗决策的影响 - 来自朴茨茅斯肿瘤学中心的经验
3. PDL1 expression in NSCLC (non-small cell lung cancer) patients and its influence on treatment decision - experience from Portsmouth Oncology Centre [J] . Gyi M. M., Gulliford T. J., Muthuramalingam S. R. Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2018,第Suppla1期

机译：NSCLC（非小细胞肺癌）患者的PDL1表达及其对治疗决策的影响 - 来自朴茨茅斯肿瘤学中心的经验
4. Enumeration and ALK Investigation of Circulating Tumor Cells in Non-Small Cell Lung Cancer (NSCLC) Patients Using an Effective In Vivo Technology, the GILUPI CellCollector? [C] . Klaus Luecke, Lukasz Gasiorowski, Stefanie Herold, International Molecular Medicine Tri-Conference. . 2015

机译：使用有效的体内技术（Gilupi Cellcollector
5. Pre-Treatment Radiomics Models for Clinical Outcomes in Early-Stage Non-Small Cell Lung Cancer (NSCLC) [D] . Shaffer, Nathan Allen. 2021

机译：早期非小细胞肺癌临床结果的预处理辐射瘤模型（NSCLC）
6. Development and validation of a decision support tool to select IMRT as radiotherapy treatment planning modality for patients with locoregionally advanced non-small cell lung cancers (NSCLC) [O] . Raj Kumar Shrimali, Santam Chakraborty, Tapesh Bhattacharyya, 2019

机译：开发和验证一种决策支持工具以选择IMRT作为局部晚期非小细胞肺癌（NSCLC）患者的放射治疗治疗方案
7. Impact of second-line (2L) immune checkpoint inhibitors (ICIs) on the treatment (Tx) of advanced non-small cell lung cancer (NSCLC) in a UK centre: A REAL-oncology analysis from the I-O Optimise initiative [O] . M. Snee, S. Cheeseman, M. Thompson, 2019

机译：二线（2L）免疫检查点抑制剂（ICIS）对英国高级非小细胞肺癌（NSCLC）治疗（TX）的影响：I-O优化倡议的实际肿瘤学分析

PDL1 expression in NSCLC (non-small cell lung cancer) patients and its influence on treatment decision - experience from Portsmouth Oncology Centre

著录项

相似文献

相关主题

期刊订阅